Overview

Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI

Status:
Completed
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
This pilot trial studies the differentiation of bone sarcomas and osteomyelitis with ferumoxytol-enhanced magnetic resonance imaging (MRI). Imaging procedures that allow doctors to more accurately differentiate between malignant bone sarcomas and osteomyelitis may help in diagnosing patients correctly and may result in more timely treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Heike E Daldrup-Link
Stanford University
Treatments:
Ferrosoferric Oxide